These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28611739)

  • 1. The PK-PD Relationship and Resistance Development of Danofloxacin against
    Zhang N; Wu Y; Huang Z; Yao L; Zhang L; Cai Q; Shen X; Jiang H; Ding H
    Front Microbiol; 2017; 8():926. PubMed ID: 28611739
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model.
    Zhang N; Wu Y; Huang Z; Zhang C; Zhang L; Cai Q; Shen X; Jiang H; Ding H
    PLoS One; 2018; 13(8):e0202070. PubMed ID: 30157201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of
    Zhang L; Kang Z; Yao L; Gu X; Huang Z; Cai Q; Shen X; Ding H
    Front Microbiol; 2018; 9():2445. PubMed ID: 30369920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and Pharmacodynamic integration of tilmicosin against
    Zhang N; Zhou M; Yan X; Liu J; Yuan S; Yang H; Ding H; Zhang D; Bai Y
    Front Vet Sci; 2022; 9():952599. PubMed ID: 36246335
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic/pharmacodynamic profiles of baicalin against Mycoplasma gallisepticum in an in vivo infection model.
    Bao J; Wu Z; Ishfaq M; Wang J; Miao Y; Niu D; Li R; Li J; Chen C
    Poult Sci; 2021 Nov; 100(11):101437. PubMed ID: 34547622
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Huang Z; Wu Y; Zhou Z; Xia X; Gu X; Cai Q; Shen X; Yang H; Ding H
    Front Pharmacol; 2019; 10():670. PubMed ID: 31293418
    [No Abstract]   [Full Text] [Related]  

  • 7. Ex vivo pharmacokinetic and pharmacodynamic analysis of valnemulin against Mycoplasma gallisepticum S6 in Mycoplasma gallisepticum and Escherichia coli co-infected chickens.
    Xiao X; Sun J; Chen Y; Zou M; Zhao DH; Liu YH
    Vet J; 2015 Apr; 204(1):54-9. PubMed ID: 25744809
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Xiao X; Pei L; Jiang LJ; Lan WX; Xiao JY; Jiang YJ; Wang ZQ
    Front Pharmacol; 2018; 9():391. PubMed ID: 29719510
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic/Pharmacodynamic Profiles of Tiamulin in an Experimental Intratracheal Infection Model of Mycoplasma gallisepticum.
    Xiao X; Sun J; Yang T; Fang X; Cheng J; Xiong YQ; Liu YH
    Front Vet Sci; 2016; 3():75. PubMed ID: 27656647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo pharmacokinetic/pharmacodynamic profiles of valnemulin in an experimental intratracheal Mycoplasma gallisepticum infection model.
    Xiao X; Sun J; Yang T; Fang X; Wu D; Xiong YQ; Cheng J; Chen Y; Shi W; Liu YH
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3754-60. PubMed ID: 25845865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum.
    Zhang N; Gu X; Ye X; Wu X; Zhang B; Zhang L; Shen X; Jiang H; Ding H
    Front Microbiol; 2016; 7():653. PubMed ID: 27199972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin.
    Zhang N; Ye X; Wu Y; Huang Z; Gu X; Cai Q; Shen X; Jiang H; Ding H
    PLoS One; 2017; 12(1):e0169134. PubMed ID: 28052123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone resistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerases on resistance level.
    Reinhardt AK; Kempf I; Kobisch M; Gautier-Bouchardon AV
    J Antimicrob Chemother; 2002 Oct; 50(4):589-92. PubMed ID: 12356806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational Use of Danofloxacin for Treatment of
    Wang S; Huang A; Gu Y; Li J; Huang L; Wang X; Tao Y; Liu Z; Wu C; Yuan Z; Hao H
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic/pharmacodynamic integration of amphenmulin: a novel pleuromutilin derivative against
    Wang W; Yu J; Ji X; Xia X; Ding H
    Microbiol Spectr; 2024 Feb; 12(2):e0367523. PubMed ID: 38112481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and typing of enrofloxacin-resistant clinical isolates of Mycoplasma gallisepticum.
    Lysnyansky I; Gerchman I; Perk S; Levisohn S
    Avian Dis; 2008 Dec; 52(4):685-9. PubMed ID: 19166064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-resistance relationship and PK/PD evaluation of danofloxacin against emergence of resistant Pasteurella multocida in an in vitro dynamic model.
    Lu TY; Sun Z; Liang LY; Zhang J; Guo WL; Wang ZY; Sun J; Liao XP; Zhou YF
    J Appl Microbiol; 2024 Jul; 135(7):. PubMed ID: 38925653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Multidrug Resistance in Nonpathogenic Mycoplasma Species Isolated from South African Poultry.
    Beylefeld A; Wambulawaye P; Bwala DG; Gouws JJ; Lukhele OM; Wandrag DBR; Abolnik C
    Appl Environ Microbiol; 2018 Nov; 84(21):. PubMed ID: 30171000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
    Li Q; Bi X; Diao Y; Deng X
    Am J Vet Res; 2007 Aug; 68(8):812-5. PubMed ID: 17669019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, Pharmacodynamic Efficacy Prediction Indexes and Monte Carlo Simulations of Enrofloxacin Hydrochloride Against Bacterial Strains That Induce Common Clinical Diseases in Broiler Chickens.
    Bonassa KPD; Miragliotta MY; Simas RC; Eberlin MN; Anadón A; Moreno RA; Reyes FGR
    Front Vet Sci; 2020; 7():606872. PubMed ID: 33490134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.